GURU.Markets stock price, segment price, and overall market index valuation
The company's share price INVO Fertility Inc
The stock price of INVO, a company offering more affordable IVF technology, reflects its efforts to make infertility treatment more accessible. Its price trajectory depends on the adoption of its technology in clinics and its competition with traditional methods.
Share prices of companies in the market segment - Specialized medical equipment
INVO Bioscience has developed an affordable in vitro fertilization (IVF) technology that allows fertilization and embryo development to occur within a woman's body. We've classified it as "Specialized Medical Equipment." The graph below shows the dynamics in the reproductive medicine sector.
Broad Market Index - GURU.Markets
INVO Bioscience is a medical company that developed and commercialized the INVOcell device, which allows for the incubation of embryos inside a woman's body. It is a component of the GURU.Markets index. The chart below represents the market. See how this company's stock compares to the reproductive technology sector.
Change in the price of a company, segment, and market as a whole per day
IVF - Daily change in the company's share price INVO Fertility Inc
INVO Fertility Inc.'s daily share price fluctuations reflect volatility in the fertility treatment sector. The index demonstrates sensitivity to demand for its more affordable IVF technology, serving as an indicator of trends in reproductive medicine.
Daily change in the price of a set of shares in a market segment - Specialized medical equipment
INVO Bioscience offers a more affordable solution for infertility treatment—the INVOcell incubation system. The reproductive medicine market is growing but sensitive to innovation. The chart below shows the volatility in the medical equipment sector, helping to assess how the market is accepting IVF technology.
Daily change in the price of a broad market stock, index - GURU.Markets
INVO Fertility offers more accessible technology for infertility treatment. This medtech company's stock price reflects the demand for reproductive services, which is driven by demographic and social trends. Its dynamics reflect the contribution of innovative medicine to overall market volatility.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization INVO Fertility Inc
For INVO Bioscience, the year-over-year trend is a story of its unique approach to infertility treatment. Its market capitalization growth over the past 12 months reflects its success in promoting its INVOcell® system, which allows for the incubation of embryos inside a woman's body, offering a more affordable and natural alternative to traditional IVF.
Annual dynamics of market capitalization of the market segment - Specialized medical equipment
INVO, as a company offering a more accessible solution for infertility treatment, is betting on the democratization of this service. Its performance relative to the sector will determine how successfully its technology is adopted in the market and how it is influenced by social and demographic trends.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
INVO Fertility, with its more accessible IVF technology, is attempting to democratize infertility treatment. Its performance relative to the market is a testament to whether its approach can achieve mass adoption. Success will allow it to grow faster than the market, carving out a unique niche in a multi-billion dollar industry.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization INVO Fertility Inc
INVO is a medical company offering an affordable IVF solution. Its monthly growth is driven by the implementation of its INVOcell technology in fertility clinics. News about the expansion of its clinic network and the increase in the number of procedures are the main drivers.
Monthly dynamics of market capitalization of the market segment - Specialized medical equipment
The market for infertility treatment technologies is growing as people postpone having children. The dynamics of this medical sector, shown in the graph, reflect the demand for affordable solutions. Companies like INVO Fertility offer their innovative IVF system in this area.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
INVO, a fertility treatment company, operates in a market where demand is driven by demographics rather than economics. The company's shares can move independently of the market, reacting to news about the effectiveness and adoption of its technology.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization INVO Fertility Inc
INVO Fertility, a company offering a more accessible and simple IVF method, is trying to change the infertility treatment market. Its weekly stock price reflects the pace of its technology's adoption in clinics, regulatory approvals in new countries, and the overall accessibility of reproductive technologies.
Weekly dynamics of market capitalization of the market segment - Specialized medical equipment
INVO Bioscience offers a more accessible and simple solution for in vitro fertilization (IVF). Its success depends on the adoption of this technology in clinics worldwide. The chart below shows how investors view its potential in the growing reproductive technology market.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
INVO Bioscience offers a more affordable IVF solution. Its success depends on the adoption of this technology in clinics. The chart shows how investors assess its potential in the growing reproductive technology market, against the backdrop of general trends.
Market capitalization of the company, segment and market as a whole
IVF - Market capitalization of the company INVO Fertility Inc
INVO Fertility's market capitalization reflects investor valuation of its unique fertility treatment technology. The chart shows the market's appreciation of its INVOcell device, which allows for embryo incubation inside a woman's body. Its low price reflects both the potential for more accessible IVF and the challenges of its widespread adoption.
IVF - Share of the company's market capitalization INVO Fertility Inc within the market segment - Specialized medical equipment
INVO Fertility (formerly INVO Bioscience) has developed a more accessible and simpler IVF method. Its market share in the medical technology sector is small, but it is an innovator. Its market capitalization reflects the potential of its INVOcell system, which uses a woman's body as a natural incubator, reducing the cost of the procedure.
Market capitalization of the market segment - Specialized medical equipment
This chart shows the overall market capitalization of the entire specialized medical equipment sector. For INVO Fertility, with its more accessible IVF technology, this line represents demographics and accessibility. The rising chart reflects the global problem of infertility and the need for simpler and more affordable solutions for millions of couples.
Market capitalization of all companies included in a broad market index - GURU.Markets
INVO Fertility has developed a more accessible and simple method of in vitro fertilization (IVF). Its market capitalization is a measure of the democratization of reproductive technologies. This represents the market share of businesses making the dream of having a child more accessible.
Book value capitalization of the company, segment and market as a whole
IVF - Book value capitalization of the company INVO Fertility Inc
INVO Bioscience has developed affordable in vitro fertilization (IVF) technology. Its book value is derived from its intellectual property (patents for the INVOcell device) and financial capital. This is the foundation for affordable infertility treatment. How has this changed? The chart below shows.
IVF - Share of the company's book capitalization INVO Fertility Inc within the market segment - Specialized medical equipment
INVO Fertility Inc. offers an innovative solution for infertility treatment. Its business relies on manufacturing facilities for its INVOcell device and operational infrastructure for managing its clinics. The chart shows its share of physical assets supporting the reproductive technology industry.
Market segment balance sheet capitalization - Specialized medical equipment
INVO Fertility (formerly INVO Bioscience) has developed a more affordable IVF method. The chart shows its share of real assets. These are its manufacturing facilities, where INVOcell devices, the physical embodiment of its innovative technology, are produced.
Book value of all companies included in the broad market index - GURU.Markets
INVO Bioscience's assets are not its clinics, but rather its INVOcell technology and device, which allows for the initial stages of IVF to be performed within a woman's body, making the procedure more accessible. The book value reflects the potential of this innovative approach to reproductive medicine.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - INVO Fertility Inc
INVO Fertility has developed a more accessible method of in vitro fertilization (IVF). Its market capitalization reflects the value of its technology and its potential to make infertility treatment accessible to more people.
Market to book capitalization ratio in a market segment - Specialized medical equipment
INVO Fertility is a medical company that has developed a more accessible technology for infertility treatment. The chart shows how investors assess its potential to make IVF more accessible to the general population, opening up a huge market.
Market to book capitalization ratio for the market as a whole
INVO Bioscience offers a more affordable IVF solution. The company strives to make infertility treatments more accessible. This chart helps understand how the market values companies that not only innovate but also democratize access to expensive medical procedures.
Debts of the company, segment and market as a whole
IVF - Company debts INVO Fertility Inc
INVO, a company producing an affordable in vitro fertilization (IVF) solution, is raising capital to expand its commercial operations and open clinics. This chart shows the investment required to advance this new medical technology in the conservative reproductive medicine market.
Market segment debts - Specialized medical equipment
INVO Bioscience has developed and commercialized the INVOcell device, which enables fertilization and early embryo development inside a woman's body, making IVF a simpler and more accessible method. The chart below shows how the company is funding the advancement of its unique technology in the assisted reproductive technology market.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio INVO Fertility Inc
INVO Fertility (formerly INVO Bioscience) developed and commercialized the INVOcell device, which enables embryo incubation inside a woman's body, making IVF more accessible. Bringing such an innovative medical technology to market requires investments in clinical research and marketing. This chart shows how the company uses debt to fuel its growth.
Market segment debt to market segment book capitalization - Specialized medical equipment
INVO Fertility has developed a more affordable method of in vitro fertilization (IVF). This chart shows how the medical device company is funding the commercialization of its technology. It compares its debt load to the market capitalization of the entire medical device sector, reflecting its go-to-market strategy.
Debt to book value of all companies in the market
INVO Fertility (formerly INVO Bioscience) offers a more affordable technology for infertility treatment. Bringing a new medical procedure to market requires investment in physician training and marketing. How dependent is the company on debt? This chart of total market debt helps evaluate its financial strategy as it moves toward widespread adoption.
P/E of the company, segment and market as a whole
P/E - INVO Fertility Inc
INVO Bioscience has developed a medical device, INVOcell, that allows for the incubation of embryos inside a woman's body, offering a more affordable alternative to traditional IVF. This chart shows how investors value it in the assisted reproductive technology market.
P/E of the market segment - Specialized medical equipment
INVO Fertility, formerly INVO Bioscience, developed the INVOcell system, which enables fertilization and early embryo development inside a woman's body, offering a more affordable alternative to IVF. This chart illustrates the average rating in the specialized medical equipment sector, which values technologies that make infertility treatment more accessible.
P/E of the market as a whole
INVO Fertility Inc. is a healthcare company that has developed and commercializes an affordable and effective in vitro fertilization (IVF) procedure. This chart reflects general trends in the healthcare sector. It helps understand how the market views INVO's innovative approach to infertility treatment, given overall sentiment and demographic trends.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company INVO Fertility Inc
INVO Bioscience has developed and commercialized the INVOcell device, which enables embryo incubation within a woman's body, making IVF more accessible and natural. This graph reflects market expectations for the future growth of the assisted reproductive technology market and the adoption of this innovative method.
%20P%2FE%20INVO%20Fertility%20Inc&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-INVO-Fertility-Inc&v=1772660727747 "Chart of the company's future (projected) P/E INVO Fertility Inc")
Future (projected) P/E of the market segment - Specialized medical equipment
INVO Fertility offers a simpler and more accessible method of in vitro fertilization (IVF) using a specialized device, the INVOcell. The chart reflects future profit forecasts for the sector, helping to understand whether investors believe this technology can make infertility treatment accessible to more couples.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Specialized%20medical%20equipment&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Specialized-medical-equipment&v=1772660727830 "Future (projected) P/E graph of the market segment - Specialized medical equipment")
Future (projected) P/E of the market as a whole
INVO Fertility offers a more affordable and simple solution for in vitro fertilization (IVF). The company strives to make fertility treatments accessible to more people. This chart of overall consumer and healthcare sentiment helps assess how much investors believe in the potential of innovations to democratize access to expensive medical services.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772660727902 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit INVO Fertility Inc
INVO Fertility Inc. (formerly INVO Bioscience) has developed a more accessible and simpler method of in vitro fertilization (IVF), where incubation occurs inside the woman's body. Profitability depends on the adoption of this technology in fertility clinics. This chart shows the financial results of its efforts to make IVF more accessible.
Profit of companies in the market segment - Specialized medical equipment
INVO Fertility Inc. offers a simpler and more affordable method of in vitro fertilization (IVF) using a patented device that incubates embryos inside a woman's body. This chart shows overall profitability in the specialized medical equipment sector, where innovations that make expensive procedures more accessible have the potential to transform the market.
Overall market profit
INVO Fertility Inc. provides a more accessible solution for infertility treatment. The need for such services is high, but their cost can be a barrier. The overall economic situation, as illustrated by this graph, influences families' financial resources and their willingness to spend on expensive medical procedures, which are not always covered by insurance.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company INVO Fertility Inc
INVO Bioscience is commercializing the INVOcell device, which allows for the incubation of eggs and sperm inside a woman's body, offering a more affordable alternative to traditional IVF. Future revenue depends on the acceptance of this technology by clinics and patients. This chart shows expectations for the assisted reproductive technology market.
%20profit%20of%20the%20company%20INVO%20Fertility%20Inc&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-INVO-Fertility-Inc&v=1772660728107 "Graph of future (projected) profit of the company INVO Fertility Inc")
Future (predicted) profit of companies in the market segment - Specialized medical equipment
INVO Fertility (formerly INVO Bioscience) developed INVOcell technology, a more affordable and natural method of in vitro fertilization (IVF). The company aims to make infertility treatment more accessible. This graph shows profitability expectations for the specialized medical device sector, helping to assess the potential of INVO's technology.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Specialized%20medical%20equipment&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Specialized-medical-equipment&v=1772660728180 "Graph of future (predicted) profits of companies in a market segment - Specialized medical equipment")
Future (predicted) profit of the market as a whole
INVO Fertility Inc. (formerly INVO Bioscience) offers a more affordable solution for in vitro fertilization (IVF). Demand for its technology depends on income and desire to have children. This economic expectations curve is important because it reflects families' ability to afford expensive medical procedures.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772660728220 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - INVO Fertility Inc
INVO Fertility offers a more accessible and simple solution for infertility treatment (IVF). Revenue growth reflects the adoption of its innovative technology by clinics and patients. This chart shows how investors view its potential to make infertility treatment accessible to a wider range of people.
P/S market segment - Specialized medical equipment
INVO Fertility (formerly INVO Bioscience) offers a more accessible and simple solution for infertility treatment—the INVOcell system, which uses a woman's body as a natural incubator for fertilization and embryo development. This chart shows the average revenue estimate for the sector, helping to assess how the market views this innovation in reproductive technology.
P/S of the market as a whole
INVO Fertility, through its subsidiary INVO Bioscience, has developed a more accessible and simpler method of in vitro fertilization (IVF). This chart, showing average revenue estimates, helps understand how investors value the company, which strives to make an important medical procedure accessible to more people.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company INVO Fertility Inc
INVO Bioscience is commercializing the INVOcell device, which allows for the incubation of embryos inside a woman's body, offering a more natural and affordable alternative to traditional IVF. Estimating future revenue is important to the company, as it reflects investor sentiment on the demand for more affordable infertility treatments and the adoption of its technology by clinics worldwide.
%20P%2FS%20INVO%20Fertility%20Inc&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-INVO-Fertility-Inc&v=1772660728389 "The graph of the company's future (projected) P/S INVO Fertility Inc")
Future (projected) P/S of the market segment - Specialized medical equipment
INVO Fertility, formerly INVO Bioscience, offers a more affordable and simpler method of in vitro fertilization (IVF) using its INVOcell device. This chart compares the company's estimated future sales with expectations for the medical device sector. It shows whether investors believe its technology can make fertility treatment accessible to more couples.
%20P%2FS%20market%20segment%20graph%20-%20Specialized%20medical%20equipment&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Specialized-medical-equipment&v=1772660728505 "Future (projected) P/S market segment graph - Specialized medical equipment")
Future (projected) P/S of the market as a whole
INVO Bioscience has developed the INVOcell medical device, which allows part of the IVF process to be performed within a woman's body, making the procedure more accessible and natural. The company's growth depends on the acceptance of this technology by clinics and patients. This graph of investor expectations reflects their confidence in innovation in the reproductive technology market.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772660728602 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales INVO Fertility Inc
For INVO Bioscience, this figure reflects revenue from its innovative and more affordable infertility treatment technology, INVOcell. Revenue growth depends on the opening of new clinics using this method and its acceptance as an alternative to traditional IVF.
Sales of companies in the market segment - Specialized medical equipment
INVO Fertility Inc. (formerly INVO Bioscience) offers a more accessible and simpler in vitro fertilization (IVF) technology called INVOcell. Its revenue breakdown shows how much of its revenue comes from sales of the device itself and how much comes from its own clinics. This reflects its dual commercialization strategy.
Overall market sales
INVO Fertility Inc. offers a more accessible and simple method of in vitro fertilization (IVF). The company aims to make infertility treatments accessible to more couples. The current economic climate impacts families' ability to afford expensive medical procedures, and INVO's innovations aim to address this issue.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company INVO Fertility Inc
INVO Bioscience is commercializing the INVOcell device, a more accessible and natural method of in vitro fertilization (IVF) that allows fertilization and early embryo development to occur within a woman's body. Sales growth is dependent on the acceptance of this technology by clinics and patients. The chart reflects expected growth in the reproductive technology market.
%20sales%20of%20the%20company%20INVO%20Fertility%20Inc&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-INVO-Fertility-Inc&v=1772660728775 "Schedule of future (projected) sales of the company INVO Fertility Inc")
Future (projected) sales of companies in the market segment - Specialized medical equipment
INVO Fertility, through INVO Bioscience, offers a more accessible and simpler method of in vitro fertilization (IVF). This chart shows the forecast for the infertility treatment market. Is demand for innovative and cost-effective solutions in reproductive medicine growing? This determines the overall outlook.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Specialized%20medical%20equipment&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Specialized-medical-equipment&v=1772660728902 "Schedule of future (projected) sales of companies in the market segment - Specialized medical equipment")
Future (projected) sales of the market as a whole
INVO Fertility (formerly INVO Bioscience) offers a more affordable solution for in vitro fertilization (IVF). IVF procedures are expensive and often not covered by insurance, so demand is sensitive to the economy. This consumer confidence chart is an important indicator for INVO, influencing families' fertility planning decisions.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772660728910 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality INVO Fertility Inc
INVO Fertility (formerly INVO Bioscience) has developed and markets the INVOcell device, which allows for the incubation of embryos inside a woman's body, offering a more affordable alternative to traditional IVF. This chart shows the company's success in commercializing its technology. Profitability depends on the widespread adoption of its method in fertility clinics.
Market segment marginality - Specialized medical equipment
INVO Bioscience, Inc. has developed a more accessible and simpler method of in vitro fertilization (IVF). The company's profitability depends on the implementation of its technology in clinics worldwide and its acceptance by patients as an alternative to traditional IVF. This graph shows its path to commercial success in the field of reproductive medicine.
Market marginality as a whole
INVO Fertility (INVO Bioscience) offers a more accessible and simpler method of in vitro fertilization (IVF). Its success depends on the acceptance of this technology by clinics and patients. This overall profitability chart reflects the state of the economy, which affects people's ability to afford expensive infertility treatments.
Employees in the company, segment and market as a whole
Number of employees in the company INVO Fertility Inc
INVO Bioscience has developed a more accessible method of in vitro fertilization (IVF) using its INVOcell device. Its small staff is focused on commercializing this technology. This chart shows how the company is building its team to open its own clinics and promote its method to doctors and patients.
Share of the company's employees INVO Fertility Inc within the market segment - Specialized medical equipment
INVO Bioscience has developed a more accessible and simpler method of in vitro fertilization (IVF). Commercializing this medical technology requires a team of sales and clinical support specialists. This chart shows the company's market share, reflecting its efforts to introduce an innovative approach to reproductive medicine.
Number of employees in the market segment - Specialized medical equipment
INVO Fertility, through its subsidiary INVO Bioscience, offers a more accessible and simpler in vitro fertilization (IVF) technology called INVOcell. The chart reflects employment in the specialized medical equipment sector. This technology has the potential to make infertility treatment accessible to many more couples.
Number of employees in the market as a whole
INVO Fertility (INVO Bioscience) offers a more accessible method of in vitro fertilization (IVF). The company's growth depends on the adoption of its technology by clinics and patients. This chart shows the big picture, and INVO is an example of a company whose innovations can make important medical services more accessible, while creating jobs in reproductive medicine.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company INVO Fertility Inc (IVF)
INVO Fertility (IVF) is a medtech company offering a more affordable IVF solution (INVOcell). Their goal is to make infertility treatment more accessible. This chart shows how the market values their disruptive technology. It reflects the market value per employee, which is a measure of their IP and the potential to transform the fertility market.
%20of%20the%20company%20INVO%20Fertility%20Inc%20(IVF)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-INVO-Fertility-Inc-IVF&v=1772660729469 "Chart of market capitalization per employee (in thousands of dollars) of the company INVO Fertility Inc (IVF)")
Market capitalization per employee (in thousands of dollars) in the market segment - Specialized medical equipment
INVO Fertility (IVF) has developed the INVOcell device, which enables the incubation of eggs and embryos inside a woman's body, offering a more affordable alternative to IVF. This metric reflects how the market values their innovation. The high market capitalization per employee suggests the potential of their technology to make infertility treatment accessible to millions of couples.
%20by%20market%20segment%20-%20Specialized%20medical%20equipment&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Specialized-medical-equipment&v=1772660729647 "Market capitalization per employee (in thousands of dollars) by market segment - Specialized medical equipment")
Market capitalization per employee (in thousands of dollars) for the overall market
INVO Fertility offers a more accessible and simple solution to infertility treatment. This figure reflects the value of its unique technology. The market appreciates the company's potential to make IVF treatment accessible to a much wider range of patients, creating a huge potential market for its medical device.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772660729687 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company INVO Fertility Inc (IVF)
INVO Fertility is the company that developed INVOcell technology, a simpler and more accessible IVF method. It's a niche MedTech. This chart shows how successfully the company sells its technology to clinics. Revenue per employee is the margin earned from the sale of each device and its consumables.
%20Chart%20INVO%20Fertility%20Inc%20(IVF)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-INVO-Fertility-Inc-IVF&v=1772660729754 "Company Profit Per Employee (in thousands of dollars) Chart INVO Fertility Inc (IVF)")
Profit per employee (in thousands of dollars) in the market segment - Specialized medical equipment
INVO Bioscience, Inc. offers more affordable in vitro fertilization (IVF) technology. In the field of reproductive medicine, efficiency per employee reflects the level of demand for their solution from clinics and patients. The graph illustrates how an innovation aimed at reducing costs can become a profitable business model.
%20in%20the%20market%20segment%20-%20Specialized%20medical%20equipment&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Specialized-medical-equipment&v=1772660729762 "Chart of profit per employee (in thousands of dollars) in the market segment - Specialized medical equipment")
Profit per employee (in thousands of dollars) for the market as a whole
INVO Fertility (IVF) is a medical technology company offering a more affordable IVF technology (INVOcell). This device allows for intrauterine incubation, reducing clinic costs. This chart helps understand the profitability per employee of a business offering an innovative, yet affordable, medical device.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772660729929 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee INVO Fertility Inc (IVF)
INVO Fertility (formerly INVO Bioscience) offers more affordable IVF technology. This chart shows how successfully the company is commercializing its innovative approach. Increased revenue per employee will indicate the adoption of their method in clinics worldwide, making fertility treatment more accessible.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-INVO-Fertility-Inc-IVF&v=1772660730057 "Sales chart per company employee INVO Fertility Inc (IVF)")
Sales per employee in the market segment - Specialized medical equipment
INVO Fertility (IVF) is a medical technology company that developed the INVOcell, a device for incubating embryos inside the body, making IVF more accessible. This graph shows the average output in the sector. For IVF, this is an indicator of how productive their R&D and sales teams are in promoting this niche technology to clinics.
Sales per employee for the market as a whole
INVO Fertility (IVF) is a company that has made IVF more accessible. Their INVOcell device allows for embryo incubation inside the body, which is cheaper than laboratory incubation. This indicator demonstrates how scalable their model (device sales plus consumables) is.
Short shares by company, segment and market as a whole
Shares shorted by company INVO Fertility Inc (IVF)
INVO Fertility (IVF) offers a simpler and cheaper method of IVF (in vitro fertilization). This chart shows the number of short positions. Sellers may doubt that this method is as effective as traditional IVF or that clinics will be willing to switch to the new technology.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-INVO-Fertility-Inc-IVF&v=1772660730216 "Short Shares Chart for the Company INVO Fertility Inc (IVF)")
Shares shorted by market segment - Specialized medical equipment
INVO Fertility (IVF) is the company that developed the INVOcell device, which allows for the incubation of fertilized eggs inside a woman's body, reducing the cost of IVF. This chart shows the overall volume of bearish bids in the specialized medical equipment sector, highlighting investor concerns about slow adoption.
Shares shorted by the overall market
INVO Fertility offers more affordable IVF technology, aiming to carve out a niche in the infertility treatment market. This chart measures general fear. When investors fear a recession, they expect consumers to postpone expensive, non-emergency medical procedures. This threatens IVO's growth plans as their clients become more price-sensitive.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator INVO Fertility Inc (IVF)
This chart for INVO Fertility is an indicator of the battle for the IVF market. The company offers a more affordable and "natural" incubation method (INVOcell), which occurs inside the body. News about an increase in the number of clinics adopting this technology or expanding insurance coverage is causing the market to "overheat" (above 70). Slow adoption and competition from traditional IVF are leading to "oversold" prices.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-INVO-Fertility-Inc-IVF&v=1772660730389 "RSI 14 indicator chart for the company's stock INVO Fertility Inc (IVF)")
RSI 14 Market Segment - Specialized medical equipment
INVO Fertility (INVO Bioscience) offers a more affordable and natural IVF method. Their INVOcell device allows fertilization and early embryo development to occur *inside* a woman's body. This chart measures the overall momentum in the specialized medical equipment sector. It helps assess how the market views this industry and whether INVO stands out from the crowd.
RSI 14 for the overall market
INVO Fertility offers reproductive medicine solutions. Demand for these services is often inelastic, but as a public company, IVF is dependent on the market climate. This market "temperature" indicator illustrates the general cycles of optimism and fear. During periods of market panic, investors may ignore IVF's fundamental successes, while euphoria can unreasonably inflate its valuation.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast IVF (INVO Fertility Inc)
INVO Bioscience is a medical technology company that created the INVOcell, a device that makes IVF more accessible by allowing fertilization to occur inside the body rather than in a lab. This chart shows the speculative average 12-month price target from analysts, based on their belief in the adoption of this technology in IVF clinics.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-IVF-INVO-Fertility-Inc&v=1772660730596 "A chart showing analyst consensus forecasts for the expected stock price. IVF (INVO Fertility Inc)")
The difference between the consensus estimate and the actual stock price IVF (INVO Fertility Inc)
INVO stands for "simplified" IVF. The company developed the INVOcell device, which allows for embryo incubation *inside* the body, making the procedure more accessible. This chart measures the gap between the current price and the consensus target price. It shows whether experts believe this "disruptive" technology will impact the fertility treatment market.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-IVF-INVO-Fertility-Inc&v=1772660730719 "A chart showing the difference between the consensus forecast and the actual stock price. IVF (INVO Fertility Inc)")
Analyst consensus forecast for stock prices by market segment - Specialized medical equipment
INVO stands for "IVF in a box." The company created INVOcell, a mini-incubator that allows for in-the-body fertilization, which is cheaper than lab-based IVF. This chart reflects analysts' overall expectations for the entire medical equipment sector. It shows whether experts believe the "affordable" IVF market will grow.
Analysts' consensus forecast for the overall market share price
INVO Fertility is a medical company that has developed a device (INVOcell) that makes IVF more accessible. This sector represents optional but expensive medical services. This chart reflects overall market sentiment. For INVO, whose business is focused on expensive discretionary spending, the overall optimism (the rising chart) is important as it reflects consumer confidence.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index INVO Fertility Inc
INVO is low-cost IVF. Their signature feature is the INVOcell, an intravaginal device (a miniature incubator) that allows fertilization and early embryo development to occur within the body, which (according to them) is cheaper than in vitro fertilization. This chart is a summary indicator of their niche technology, reflecting their (slow) path to clinical adoption.
AKIMA Market Segment Index - Specialized medical equipment
INVO Fertility (IVF) offers an alternative to traditional IVF. Their INVOcell device allows for part of the fertilization process and early embryo development to be performed inside the body, which is less expensive. This chart compares their composite index to the sector, showing how competitive their affordable IVF technology is.
The AKIM Index for the overall market
INVO Fertility is a medtech company offering INVOcell, a device for intravaginal embryo culture (an alternative to IVF). This chart, reflecting the market average, is a backdrop. It helps assess how IVF, which makes reproductive technologies more accessible, compares to overall macroeconomic trends.
